Understanding the molecular mechanisms of these endocytic pathways and the role of SDCs in regulating protein aggregation provides valuable insights into the pathogenesis of neurodegenerative diseases—including Parkinson’s disease, as both earlier and more recent studies have implicated SDC3 in its development, potentially opening new avenues for therapeutic intervention [59,60]. This evidence concerns the gene SDC3 and neurodegenerative disease.